Biosynthetic Human Insulin – Current Status and Outlook by 2020

Human biosynthetic insulin derived fro E. coli or yeast has virtually replaced insulin from bovine and porcine pancreas. The production process for recombinant insulin is estimated for E. coli and yeast, comprising:

• cost of insulin precursor
• cost for bioactivation and purification of the precursor to insulin

The worldwide insulin market for 2020 is given, producers and their market share discussed and the growth prospects for insulin are reviewed.

Click here to contact us for further information.

What's New

Yeast ß-Glucans in Sports Medicine ß-glucans are polysaccharides linked by glycosidic bonds which occur in cell walls from bak.....

read more»»

Genetically modified wheat Many cereals especially wheat are often infested with insects such as sap-sucking aphids. Farmers t.....

read more»»

Protein for Sports Nutrition This is the era of proteins, especially soya proteins. These were launched over 60 years ago by U......

read more»»

A Tale of Two Monoclonal Antibodies A major problem has arisen regarding two monoclonal antibodies Lucentis [ranibizumab] and Avastin [.....

read more»»

Have your Antimicrobial – and eat it Preservatives prevent the microbial spoilage of foods especially meats by preventing the growth of o.....

read more»»

Contact Info

L. Hepner & Associates
48 Portland Place, London W1B 1NG,
United Kingdom
phone: +44 20 7631 3194